Skip to main content
Clinical Trials/ITMCTR2000003245
ITMCTR2000003245
Recruiting
Phase 1

ingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial

The First Afflicated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
novel coronavirus pneumonia (COVID-19)
Sponsor
The First Afflicated Hospital of Guangzhou University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Afflicated Hospital of Guangzhou University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. in line with epidemiological history survey and negative forCOVID\-19 RNA screening
  • 2\. in line with inclusion criteria and voluntarily receive fire needle treatment
  • 3\. Aged 18 to 65 years old;
  • 4\. Quality of life score\<\=37;
  • 5\. Voluntary participation in this study and sign informed consent.

Exclusion Criteria

  • 1\. People who are taking anticoagulant drugs (such as warfarin), or have received other related treatments, may affect the indicators of this study;
  • 2\. Pregnant women;
  • 3\. Those who cannot tolerate fire needles due to allergies, stress, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Fire needle plus cupping on pain improvement in patients with herpes zoster:a randomized controlled trial
ITMCTR2100005390Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Recruiting
Phase 1
Clinical observation of fire needle combined with halometasone cream in the treatment of acral vitiligoVitiligo
ITMCTR2100004789Dermatology Hospital,Southern Medical University
Active, not recruiting
Phase 1
Improvement of outcome and reduction of toxicity in elderly patients withCD20+ aggressive B-cell lymphoma by an optimised schedule of themonoclonal antibody rituximab, substitution of conventional by anothervincristine and FDG-PET based reduction of therapy in combination withvitamin D substitutioDiffuse large B-cell lymphomaMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-019587-36-DEniversität des Saarlandes1,152
Not yet recruiting
Not Applicable
Effect of fire needle therapy on mild-moderate benign prostatic hyperplasia: Protocol for a randomized controlled pilot trial
ITMCTR2000003205Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Active, not recruiting
Not Applicable
Treatment of various types of warts by needling technique.Health Condition 1: null- Age â?¥ 5 years and verrucae â?¥ 3 verrucae other than anogenital verrucae were included.
CTRI/2017/10/010302HBT Medical College and Dr R N Cooper Hospital